Roxadustat inhibits HIF prolyl hydroxylase enzymes (HIF-PH), preventing the degradation of hypoxia-inducible factor (HIF) transcription factors. This increases HIF activity, leading to:
১০০% অরিজিনাল পণ্যের নিশ্চয়তা
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Renesis 50 (Roxadustat) is the first-in-class orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It promotes erythropoiesis by:
ওয়েবসাইট থেকে অর্ডার করার সহজ ভিডিও গাইড।
অ্যাপ থেকে অর্ডারের সহজ ভিডিও গাইড
অ্যাপ ডাউনলোডePharma অ্যাপ ডাউনলোড বিস্তারিত গাইড ›অ্যাপে অর্ডারের বিস্তারিত গাইডRenesis 50 is indicated for the treatment of symptomatic anemia in adult patients associated with chronic kidney disease (CKD).
Roxadustat should be taken three times per week, ensuring non-consecutive days, and the dose must be tailored to achieve and maintain hemoglobin (Hb) levels between 10–12 g/dL.
Follow this progression for dose adjustments (up or down):
20 mg → 40 mg → 50 mg → 70 mg → 100 mg → 150 mg → 200 mg → 250 mg → 300 mg → 400 mg (for dialysis patients only).
Do not administer to women that may be pregnant or pregnant. Roxadustat is contraindicated during breast-feeding.
Phosphate Binders or Multivalent Cation-Containing Products:
Gemfibrozil or Probenecid:
Statins (Simvastatin, Rosuvastatin, Atorvastatin):
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.